Alliance Wealth Management Group Has $552,000 Position in Colgate-Palmolive (NYSE:CL)

Alliance Wealth Management Group lowered its stake in Colgate-Palmolive (NYSE:CL) by 52.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 7,330 shares of the company’s stock after selling 8,010 shares during the period. Alliance Wealth Management Group’s holdings in Colgate-Palmolive were worth $552,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently modified their holdings of CL. Beach Investment Management LLC. acquired a new position in shares of Colgate-Palmolive in the second quarter worth approximately $3,954,000. Summit Financial Group Inc. acquired a new position in Colgate-Palmolive in the second quarter valued at approximately $1,206,000. Trexquant Investment LP acquired a new position in Colgate-Palmolive in the second quarter valued at approximately $623,000. Canada Pension Plan Investment Board lifted its stake in Colgate-Palmolive by 9.4% in the second quarter. Canada Pension Plan Investment Board now owns 1,914,823 shares of the company’s stock valued at $141,946,000 after buying an additional 164,576 shares during the period. Finally, Wetherby Asset Management Inc. lifted its stake in Colgate-Palmolive by 2.5% in the second quarter. Wetherby Asset Management Inc. now owns 19,371 shares of the company’s stock valued at $1,436,000 after buying an additional 469 shares during the period. Institutional investors own 72.85% of the company’s stock.

Several equities analysts have issued reports on the company. Zacks Investment Research lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Tuesday, October 17th. Macquarie upgraded Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 price objective for the company in a report on Tuesday, December 19th. BNP Paribas downgraded Colgate-Palmolive from an “outperform” rating to an “underperform” rating in a report on Tuesday, January 30th. Citigroup upped their price target on Colgate-Palmolive from $75.00 to $80.00 and gave the stock a “neutral” rating in a report on Tuesday, January 30th. Finally, Deutsche Bank started coverage on Colgate-Palmolive in a research report on Wednesday, December 13th. They issued a “hold” rating and a $75.00 price objective on the stock. Three research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and five have issued a buy rating to the company. Colgate-Palmolive currently has a consensus rating of “Hold” and an average target price of $77.71.

Colgate-Palmolive (NYSE:CL) opened at $70.30 on Wednesday. The firm has a market capitalization of $61,730.00, a PE ratio of 30.83, a price-to-earnings-growth ratio of 2.60 and a beta of 0.75. The company has a quick ratio of 0.34, a current ratio of 0.47 and a debt-to-equity ratio of 24.42. Colgate-Palmolive has a one year low of $67.19 and a one year high of $77.91.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, January 26th. The company reported $0.75 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.75. The business had revenue of $3.89 billion for the quarter, compared to analyst estimates of $3.92 billion. Colgate-Palmolive had a return on equity of 1,716.69% and a net margin of 13.10%. The company’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same period in the prior year, the company earned $0.75 EPS. equities analysts predict that Colgate-Palmolive will post 3.18 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, February 15th. Stockholders of record on Tuesday, January 23rd will be given a dividend of $0.40 per share. The ex-dividend date is Monday, January 22nd. This represents a $1.60 annualized dividend and a dividend yield of 2.28%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 70.18%.

In other news, insider Jennifer Daniels sold 7,375 shares of the firm’s stock in a transaction that occurred on Wednesday, December 13th. The stock was sold at an average price of $73.18, for a total value of $539,702.50. Following the completion of the transaction, the insider now owns 38,691 shares in the company, valued at approximately $2,831,407.38. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, COO Noel R. Wallace sold 126,304 shares of the firm’s stock in a transaction that occurred on Wednesday, January 31st. The shares were sold at an average price of $73.78, for a total value of $9,318,709.12. Following the completion of the transaction, the chief operating officer now owns 305,631 shares of the company’s stock, valued at approximately $22,549,455.18. The disclosure for this sale can be found here. Insiders have sold a total of 406,869 shares of company stock worth $29,040,662 over the last quarter. Corporate insiders own 1.02% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This piece of content was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece of content on another domain, it was stolen and reposted in violation of U.S. & international copyright & trademark laws. The correct version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/02/14/alliance-wealth-management-group-sells-8010-shares-of-colgate-palmolive-cl.html.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply